As of 2025-05-24, the Intrinsic Value of Cipher Pharmaceuticals Inc (CPH.TO) is 17.45 CAD. This CPH.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 12.42 CAD, the upside of Cipher Pharmaceuticals Inc is 40.50%.
The range of the Intrinsic Value is 9.93 - 60.97 CAD
Based on its market price of 12.42 CAD and our intrinsic valuation, Cipher Pharmaceuticals Inc (CPH.TO) is undervalued by 40.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 9.93 - 60.97 | 17.45 | 40.5% |
| DCF (Growth 10y) | 8.31 - 47.28 | 14.07 | 13.3% |
| DCF (EBITDA 5y) | 16.73 - 23.44 | 21.58 | 73.7% |
| DCF (EBITDA 10y) | 18.82 - 27.48 | 24.66 | 98.5% |
| Fair Value | 15.47 - 15.47 | 15.47 | 24.57% |
| P/E | 6.87 - 12.14 | 9.93 | -20.0% |
| EV/EBITDA | 4.30 - 9.82 | 5.82 | -53.2% |
| EPV | (6.49) - (7.86) | (7.17) | -157.8% |
| DDM - Stable | 10.13 - 66.25 | 38.19 | 207.5% |
| DDM - Multi | 6.26 - 31.74 | 10.45 | -15.9% |
| Market Cap (mil) | 318.20 |
| Beta | -0.20 |
| Outstanding shares (mil) | 25.62 |
| Enterprise Value (mil) | 349.43 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.56% |
| Cost of Debt | 5.00% |
| WACC | 5.28% |